Osborne Clarke and Gunderson Dettmer advised G2 Venture Partners on its investment. 1KOMMA5° has raised €215 million in its Series B financing round. As a result,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Neuron23 on the deal. Neuron23, a biotechnology company, announced its $100 million Series C financing led by SoftBank Vision Fund 2. Neuron23 focuses on...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Seismic Therapeutic, Inc. on the deal while Gunderson Dettmer represented Lightspeed Venture Partners. Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for...
You must be a Standard 1 Year member to access this content.
